Smith and Nephew Plc New SNN

Healthcare Medical Devices

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image...

NYSE:SNN - Post by User

Smith and Nephew Plc New

<< Previous

Bullboard Posts

Next >>

(24)
•••

Comment by radcaton Oct 30, 2022 11:15am

95 Views

Post# 35058480

RE:RE:RE:Div makes this attractive

Since you are a Divi hound, check out Energy Transfer (ET). I have followed them since early 2022 when their share price was at $8.00 U.S. with a dividend of $0.62 U.S. The dividend has been raised each quarter since then. This pas week it was increased from $0.92 U.S. to $1.06. Management has stated they want the dividend back to Pre covid-19 level of $1.22. I believe that will happen when they report Q-4 or 2022 results. Closed Friday at $12.53 U.S. Dividend $1.06 Yield 8.53% Hard to believe the share price was $4 bucks with a yield of 20%

<< Previous

Bullboard Posts

Next >>

AI humanoid robotics maker reports financial gains